EVIVE Biotechnology
11 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of A-319 in Patients With Relapsed or Refractory B-cell Lymphoma (NCT04056975) | EVIVE Biotechnology | 2019-09-15 |
| Study to Compare the Efficacy and Safety of F-627 and GRAN® (NCT04174599) | EVIVE Biotechnology | 2018-04-12 |
| Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (NCT03252431) | EVIVE Biotechnology | 2018-04-12 |
Track EVIVE Biotechnology automatically
Every clearance here is in the API, with alerts when new ones post.